NCT02613988 - Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

January 12, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Adult Glioblastoma

Interventions

DEVICE

3 Tesla magnetic resonance imaging

High resolution structural imaging (contrast-enhanced T1-weighted image, T2-weighted image, Fluid-attenuated inversion recovery)

DEVICE

Chemical exchange saturation transfer MRI

Amide proton transfer-weighted image

DEVICE

Diffusion weighted MRI

diffusion-weighted image with b value 0, 1000, and 3000

DEVICE

Dynamic susceptibility contrast MRI

dual echo EPI sequence

Trial Locations (1)

RECRUITING

Asan Medical Center, Seoul